FDA issued a Warning Letter to AllerQuest LLC on 6/24/2019 for a later inspection.
483 AllerQuest Dec 2012

483 AllerQuest Dec 2012

$119 - Not in Stock

FDA investigators audited the AllerQuest - Plainville, CT, United States facility and issued inspectional observations (via FDA 483) on 19 Dec 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Dec 2012
  • Location: Plainville, United States
  • FEI: 3006900385

Pre-Order Not Available